RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 98 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,522 | -85.6% | 110 | -89.7% | 0.00% | – |
Q2 2023 | $17,529 | +2082.9% | 1,063 | +2262.2% | 0.00% | – |
Q1 2023 | $803 | -38.7% | 45 | 0.0% | 0.00% | – |
Q4 2022 | $1,310 | +31.0% | 45 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 45 | -65.4% | 0.00% | – |
Q1 2022 | $1,000 | -96.9% | 130 | -95.9% | 0.00% | – |
Q4 2021 | $32,000 | +3100.0% | 3,164 | +3195.8% | 0.00% | – |
Q3 2021 | $1,000 | -66.7% | 96 | -29.4% | 0.00% | – |
Q2 2021 | $3,000 | -72.7% | 136 | -72.5% | 0.00% | – |
Q1 2021 | $11,000 | -56.0% | 494 | -40.4% | 0.00% | – |
Q4 2020 | $25,000 | +150.0% | 829 | +79.8% | 0.00% | – |
Q3 2020 | $10,000 | +400.0% | 461 | +339.0% | 0.00% | – |
Q2 2020 | $2,000 | -33.3% | 105 | +6.1% | 0.00% | – |
Q1 2019 | $3,000 | – | 99 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 909,258 | $10,475,000 | 3.58% |
NEA Management Company, LLC | 4,912,306 | $56,590,000 | 1.64% |
RA Capital Management | 4,871,067 | $56,115,000 | 1.22% |
Pinz Capital Management, LP | 148,475 | $1,710,000 | 1.07% |
Samsara BioCapital, LLC | 345,293 | $3,978,000 | 1.00% |
Bell & Brown Wealth Advisors, LLC | 117,400 | $1,352,000 | 0.61% |
Rock Springs Capital Management LP | 1,237,026 | $14,251,000 | 0.36% |
ACT CAPITAL MANAGEMENT, LLC | 27,500 | $317,000 | 0.34% |
Endurant Capital Management LP | 105,792 | $1,219,000 | 0.32% |
Baker Brothers Advisors | 4,125,062 | $47,521,000 | 0.27% |